Reata Pharmaceuticals
Major Drugs - Plano, TX, US
Reata Pharmaceuticals Employees
Reata Pharmaceuticals Senior Management
Nicole Wright
C- Suite Executive Assistant to the CCO, CHRO, CDO and VP of Global Regulatory Affairs
Nicole Wright
C- Suite Executive Assistant to the CCO, CHRO, CDO and VP of Global Regulatory Affairs
Nicole Alison Wright
C- Suite Executive Assistant to the CCO, CHRO, CDO and VP of Global Regulatory Affairs
Reata Pharmaceuticals Details
Pronounced /ree-AH-tah/Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata's two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Technologies
Email Providers
Outlook
CMS
Drupal
Support and Feedback
Zendesk
Other
Microsoft Office 365
Hosting
CloudFlare Hosting